Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
Adam M. Brickman(Columbia University), Richard Mayeux(Columbia University), Danurys Sanchez(Columbia University Irving Medical Center), Jennifer J. Manly(Alzheimer’s Disease Neuroimaging Initiative), Andrew F. Teich(Columbia University), Min Suk Kang(NewYork–Presbyterian Hospital), Dolly Reyes‐Dumeyer(Columbia University), Rafael Lantigua, Lawrence S. Honig(Columbia University), Jean Paul Vonsattel(Harvard University), Jeffrey L. Dage(Indiana University School of Medicine)
Cited by 30
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k